Fidelity Investments’s THERAGENICS CORP TGX Stock Holding History
Bought
Maintained
Sold
Fidelity Investments's TGX Position: Q4 2013 in Review
Fidelity Investments sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 3,085,117 shares — an estimated $6.73M sold.
Fidelity Investments first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $6.73M in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.
- Fidelity Investments reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
- Fidelity Investments sold 3,085,117 THERAGENICS CORP shares in Q4 2013, an estimated $6.73M.
- Fidelity Investments first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
- Fidelity Investments's THERAGENICS CORP position peaked at $6.73M in Q3 2013.
- 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.
Based on Fidelity Investments's 13F filing for Q4 2013, filed 13 Feb 2014.